MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Oct 17 closing price
Price
$229.57
Change
+$2.70 (+1.19%)
Capitalization
405.55B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABBV with price predictions
Oct 17, 2025

Momentum Indicator for ABBV turns negative, indicating new downward trend

ABBV saw its Momentum Indicator move below the 0 level on October 14, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ABBV moved out of overbought territory on October 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for ABBV turned negative on October 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABBV broke above its upper Bollinger Band on September 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 366 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 376 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (243.902) is very high in comparison to the industry average of (9.785). ABBV's P/E Ratio (109.319) is considerably higher than the industry average of (24.212). Projected Growth (PEG Ratio) (0.413) is also within normal values, averaging (2.012). Dividend Yield (0.029) settles around the average of (0.028) among similar stocks. ABBV's P/S Ratio (6.978) is slightly higher than the industry average of (3.527).

View a ticker or compare two or three
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABBV is expected to report earnings to fall 6.40% to $2.78 per share on October 31

ABBVIE ABBV Stock Earnings Reports
Q3'25
Est.
$2.78
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.08
The last earnings report on July 31 showed earnings per share of $2.97, beating the estimate of $2.96. With 7.15M shares outstanding, the current market capitalization sits at 405.55B.
A.I.Advisor
published Dividends

ABBV is expected to pay dividends on November 14, 2025

ABBVIE ABBV Stock Dividends
A dividend of $1.64 per share will be paid with a record date of November 14, 2025, and an ex-dividend date of October 15, 2025. The last dividend of $1.64 was paid on August 15. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHX26.290.13
+0.50%
Schwab US Large-Cap ETF™
USO67.980.17
+0.25%
United States Oil
DEXC58.28-0.02
-0.03%
Dimensional Emerging Markets ex China Core Equity ETF
BSMP24.55-0.02
-0.07%
Invesco BulletShares 2025 Muncpl Bd ETF
LQDB88.36-0.10
-0.12%
iShares BBB Rated Corporate Bond ETF

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with AMGN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+1.19%
AMGN - ABBV
59%
Loosely correlated
+1.01%
PFE - ABBV
54%
Loosely correlated
+1.16%
BIIB - ABBV
47%
Loosely correlated
+0.52%
NVS - ABBV
45%
Loosely correlated
+0.50%
JNJ - ABBV
43%
Loosely correlated
+0.57%
More